from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3670/ephE

LFCtreatmentdescriptionclass of inhibitor

0.548

Amikacinug/mL Amikacintranslation

-0.638

Cap5-10ug/mL Capreomycintranslation

0.120

Rox10-50 ug/mL Roxithromycintranslation

-0.143

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.551

Rif0.2-5ug/mL Rifampicintranscription

0.449

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.321

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.374

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.473

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.110

Clofazimine10-13 ug/mL Clofaziminerespiration

0.160

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.533

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.808

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.556

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.154

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.767

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.699

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.859

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.412

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.736

Nigericin50 uM Nigericinrespiration

0.546

TRC10-150 ug/mL Triclosanrespiration

-0.282

TRZ10-25 ug/mL Thioridazinerespiration

-1.165

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.904

menadione6-10 ug/mL Menadionerespiration

0.093

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.049

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.206

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.331

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.579

NRP_1Non-replicating persistence stage 1dosRassociated

-0.435

Amp0.2mg/mL AmpicillincellWall

-0.310

Cephalexin20-100 ug/mL CephalexincellWall

1.160

Cerulenin0.32-5 ug/mL CerulenincellWall

0.930

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.197

EMB10-20 ug/mL EthambutolcellWall

-0.317

Eta12-40 ug/mL EthionamidecellWall

-0.478

INH0.2-0.4 ug/mL IsoniazidcellWall

0.552

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.121

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.616

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

2.187

BZA0.12 mg/mL BenzamidearomaticAmides

0.786

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.891

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.013

H2O24 mM hydrogen peroxideDNAdamaging

-0.142

Levo10 ug/mL LevofloxacinDNAdamaging

0.327

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.828

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.550

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.372

UVUV-irradiationDNAdamaging

-0.562

ARP41-4 ug/mL Antitubercular compound ARP4?

1.624

Antimycin12.5-50 ug/mL Antimycin A?

-0.467

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.066

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.362

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.527

PA8240.2-2 ug/mL PA-824?

-0.830

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.198

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.696

Verapamil50 uM Verapamil?

-0.691

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.837

methoxatin10-20 ug/mL Methoxatin?